Trial intelligence / Profile preview

Pamidronate in Inflammatory Back Pain (PEPTIDE)

NCT01799616Phase 2Unknown

Sponsor
Centre Hospitalier Universitaire de Clermont-Ferrand
Start
Jan 2013
Primary completion
Jan 2015
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of pamidronate in intervertebral disc degeneration (DDD), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Status: unknown.

02

Drugs

pamidronate
03

Conditions

intervertebral disc degeneration (DDD)

Beyond the preview

Go deeper on NCT01799616.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01799616.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call